Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Regennova Inc
Profile last edited on: 2/27/2023      CAGE: 8X9J5      UEI: K9VQL9BKC1A9

Business Identifier: Combatting life-threatening disorders, Restoring immune balance to infection and Injuries
Year Founded
2021
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3326 Durham-Chapel Hill Boulevard
Durham, NC 27707
   (919) 656-7835
   info@regennova.com
   www.regennova.com
Location: Single
Congr. District: 04
County: Durham

Public Profile

Regennova, Inc. Is a startup biotech company dedicated to developing novel therapeutics for inflammatory diseases and neurological disorders such as Cerebral Stroke, Traumatic Brain Injury and Alzheimer’s disease.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$499,900
Phase II Dollars
$0
Total Awarded
$499,900

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 1 NIH $500,000
Project Title: A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
2022 1 NIH $499,900
Project Title: Therapeutic Reduction of Cerebral Amyloid Angiopathy Pathologies in ADRD

Key People / Management

  Fengqiao Li -- Chairman of the board

  Michael P Vitek -- Founder | Chief Regulatory Officer

Company News

There are no news available.